Abstract
Toll-like receptor-3 (TLR3), a member of the pathogen recognition receptor family, has been reported to activate immune response and to exhibit pro-apoptotic activity against some tumor cells. However it is unclear whether TLR3 has same function against chicken lymphoma. In this paper we investigated the effect of TLR3 activation on a Marek’s disease lymphoma-derived chicken cell line, MDCC-MSB1. The TLR3 agonist poly (I:C) activated TLR3 pathway and inhibited tumor cells proliferation through caspase-dependent apoptosis. Using pharmacological approaches, we found that an interferon-independent mechanism involving Toll-IL-1-receptor domain-containing adapter-inducing IFN-α (TRIF) and nuclear factor κB (NF-κB) causes the apoptosis of MDCC-MSB1 cells. This is the first report about the function of TLR3 in chicken T-cell lymphoma, especially in signal pathway. The mechanisms underlying TLR3-mediated apoptosis may contribute to the development of new drug to treat lymphomas and oncovirus infections.
Similar content being viewed by others
Introduction
Double-stranded RNA (dsRNA) is a typical pathogen-associated molecular pattern (PAMP), representing either genomic or life cycle intermediate material of many viruses. It is recognized by Toll-like receptor 3 (TLR3), double-stranded RNA-activated protein kinase (PKR), retinoic acid-inducible gene I protein (RIG-I) and melanoma differentiation-associated protein 5 (MDA5), resulting in a strong antiviral response through type I interferon (IFN) response1. Moreover, the dsRNA analog poly (I:C) induces apoptosis in different cell types, apparently through multiple pathways2,3,4,5. In particular, poly (I:C) leads to the apoptosis of several tumor cell types, including head and neck cancer, lung cancer, prostate cancer, and breast cancer, suggesting a significant role for the TLR3 pathway in immune response against tumor6,7,8,9,10.
dsRNA binding leads to TLR3 dimerization and activation of its Toll-IL-1-receptor (TIR) cytoplasmic domain, which recruits the adapter molecule TIR domain-containing adapter inducing IFN-α (TRIF). TRIF continues to recruit tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6) and the receptor interacting protein 1 (RIP1) serine–threonine kinase to activate NF-κB, or TRAF3 for the activation of IFN regulatory factor 3 (IRF3) and the type I IFN response11. Both NF-κB and IRF3 are involved in cell survival and apoptosis6, 12. In addition, some reports indicated that other protein involved in TLR3 pathway such as RIP1, TRIF and TRAF6 can directly or indirectly regulate apoptosis13,14,15,16.
Marek’s disease, which is caused by Marek’s disease virus (MDV), presents with typical T-cell lymphomas clinical symptom and solid visceral tumors that contain transformed CD4+ T cells17. MDV-chicken is a well-defined small-animal model for understanding some of the principles of human disease, in particular, general tumorigenesis, and virus-induced lymphomagenesis18. Although activation of TLR3 pathway has been reported to cause apoptosis of various tumor cells, no evidence indicates whether it is effective on lymphomas. TLR3 function was found to be repressed when the MDV infection enters the tumor transformation phase19, 20. Additionally, poly (I:C) inhibited lymphomas development in chicken, suggesting a potential powerful mechanism from TLR3 activation that targets lymphoma21. However it is still unclear how the TLR3 pathway achieves this function. In this study, we investigated the effects of poly (I:C) on Marek’s disease lymphoma-derived chicken cell line and explored the TLR3-dependent signaling pathways that drive apoptosis in lymphomas cells.
Results
Poly (I:C) directly induces apoptosis in MDCC-MSB1 cell
To investigate the effect of TLR3 agonist on chicken lymphoma, the Marek’s disease lymphoma-derived chicken cell line MDCC-MSB1 cells and the avian leukosis virus (ALV) lymphoma-derived chicken cell line DT40 cells were cultured with 1 μg/ml, 10 μg/ml or 100 μg/ml dsRNA analog poly (I:C) for 24 h. All three groups of MDCC-MSB1 cells showed a significant decrease in cell viability as measured by a CCK-8 assay, with a dosage of 100 μg/ml exhibiting the most dramatic decrease (Fig. 1A). No significant change of cell viability was found in DT40 cells stimulated with poly(I:C). The decrease in cell viability due to apoptosis was further illustrated by annexin V and PI staining. Poly (I:C) induced significant dose-dependent apoptosis in MDCC-MSB1 cell line, with an apoptotic percentage range from 20.76 to 30.48% (Fig. 1B). At the same time, apoptosis at different times was also measured by CCK-8 assay and annexin V staining (Fig. 1C,D). All of the results demonstrated that poly(I:C) directly induced the apoptosis of chicken T-cell lymphoma in a dose-dependent manner.
Poly (I:C) triggered activation of intrinsic and extrinsic caspase cascades
The function of caspases in apoptosis induced by TLR3 agonist was accessed. Caspase activity was measured in the culture medium as well as in cells treated with poly (I:C) using relative light units (RLU) of luminescence at 8, 16, and 24 h. The activity of caspases 3/7, 8, and 9 was significantly enhanced from 8 h to 24 h in poly (I:C) treated cells compared to untreated cells (Fig. 2A). Then, MDCC-MSB1 cells were pre-treated with 10 μM of the pan-caspase inhibitor Z-VAD-FMK for 2 hours followed culture with poly (I:C) for 24 h. The effect of Z-VAD-FMK was measured by cell viability, annexin V staining, and caspase activity (Fig. 2C–E). The activity of caspases 3/7, 8, and 9 was inhibited completely in the Z-VAD-FMK-treated group. Moreover, Z-VAD-FMK-treated group was equivalent to the control group, indicating that the death of MDCC-MSB1 cells occurred entirely through a caspase-dependent mechanism. We also found that the necrostatin-1 had no effect on MDCC-MSB1 cells death induced by poly (I:C). It suggested that the MDCC-MSB1 cell death induced by poly (I:C) was apoptosis rather than necroptosis. The activation of caspases 8 and 9 represents extrinsic and intrinsic caspase cascades. In other words, both extrinsic and intrinsic caspase cascade participated in the apoptosis process. At the same time, we investigated mitochondria membrane potential (MMP) of MDCC-MSB1 cells treated with poly (I:C) by JC-1 dye staining. At 24 hours, MMP was almost completely down-regulated in cells treated with poly (I:C) (Fig. 2B). This result confirmed the involvement of the intrinsic caspase cascade in the apoptosis process.
Pro-apoptotic molecules and adaptors involved in TLR3 pathway were up-regulated during the apoptosis
To investigate the possible molecular mechanism of poly (I:C)-triggered MDCC-MSB1 cell apoptosis, the expression of several factors associated with apoptosis were detected by real-time PCR (Fig. 3A). At 8 h, Fas and Bcl-2 were significantly up-regulated, whereas Bak and p53 remained unchanged. Besides significant increase of Bak and p53, a dramatic up-regulation of Fas transcript was found at 16 and 24 h. No significant change of Bcl-2 and Bcl-xl was found at 16 and 24 h. Compared with MDCC-MSB1 cells, no significant up-regulation of anti-apoptotic and pro-apoptotic expression was found in DT40 cells stimulated with poly(I:C). Taken together, the up-regulation of pro-apoptotic factors further confirmed that poly(I:C) induces the apoptosis of MDCC-MSB1 cells via both intrinsic and extrinsic apoptosis pathway.
At the same time, a series of adaptors and down-stream factors involved in the TLR3 pathway were assessed by real-time PCR to further characterize TLR3 activation (Fig. 3B). At 8 h, the molecules associated with production of type I IFN were significantly up-regulated except for IRF3, whereas the adaptors related to NF-κB activation remained unchanged. Without IRF3 and NF-κB p65, almost all of these adaptors were significantly up-regulated at 16 h and 24 h. As typical downstream effectors, IFN-β and TNF-α obviously increased at each time point, but their function during apoptosis were undefined. Similarly, TLR3 and IFN-β were also up-regulated in DT40 cells stimulated with poly(I:C), but we have not found any apoptosis in DT40 cells (Fig. 3C). According to the results of western-blot analysis, up-regulation of TLR3 and phosphorylation of NF-κB p65 were confirmed, which is the activation of TLR3 pathway (Fig. 3D).
TRIF is involved in MDCC-MSB1 cell apoptosis induced by poly (I:C), independently of PKR
TRIF is the critical adaptor protein that connects TLR3 and downstream signaling cascade. The inhibitors Pepinh-TRIF and 2-Aminopurine were used to efficiently suppress TRIF and PKR activation, respectively, to determine whether PKR or TLR3 was involved in dsRNA-induced MDCC-MSB1 cell apoptosis. The suppression of TRIF with the specific inhibitor effectively attenuated poly (I:C)-induced apoptosis, whereas apoptosis occurred normally after the inactivation of PKR (Fig. 4C,D). At the same time, the inhibitor Pepinh-TRIF significantly decrease the activity of caspases 3/7, 8, and 9, suggesting a role for TRIF in initiation of caspase activation (Fig. 4E). Although the highest work concentration of Pepinh-TRIF was used in this work according to the manufacturer’s instructions, it can only efficiently inhibit rather than completely prevent poly (I:C)-induced apoptosis and caspase activity, which can be ascribe to the lower inhibitory effect in avian cells (an inhibition of 50–60%, Fig. 4A) than in mammal cells. Taken together, these data demonstrate that synthetic dsRNA induces the apoptosis of MDCC-MSB1 cells in a TRIF-dependent manner without PKR involvement.
TLR3-induced apoptosis is mediated by NF-κB activation independent of type I IFN signaling
TLR3 has been known to mediate type I IFN response and NF-κB activation through TRIF. To determine whether a type I IFN response or NF-κB activation was involved in dsRNA-induced apoptosis of MDCC-MSB1 cells, the activation of each pathway was efficiently suppressed using specific inhibitors BX795, resveratrol and BAY11-7082. According to the results, the suppression of NF-κB activation prevented poly (I:C)-triggered and TLR3-mediated apoptosis and caspase activation, whereas inhibition of type I IFN response was ineffective at decreasing cell death (Fig. 5C–E). Moreover, the suppression of NF-κB activation significantly decreased the transcription of Fas and Bak (Fig. 5F). It revealed that NF-κB activation regulated dsRNA-induced MDCC-MSB1 cell apoptosis through Fas and Bak. Collectively, the possible contribution of NF-κB activation to the poly(I:C)-induce cell apoptosis is to regulate expression of molecules involved in cell death and survival rather than pro-inflammatory cytokines.
Discussion
We elucidate how the dsRNA analog poly (I:C) leads to apoptosis of MDCC-MSB1 cells. The lymphoma cells after poly (I:C) treatment were characterized by rapid apoptosis that required a caspase cascade activated by TRIF and NF-κB. Although it has been reported that poly (I:C) can induce apoptosis in several tumor cell types including head and neck cancer, lung cancer, prostate cancer, breast cancer and others3, 6, 8,9,10, 22, 23. Moreover, Kalai et al. first reported that dsRNA was able to induce apoptosis of human T lymphoma cell line Jurkat24. In their report, poly (I:C)-treatment initiated different death signaling pathways, leading to either necrotic or apoptotic cell death. Kalai et al. have found that caspase-8 and Fas-associated with death domain (FADD) were required and not “dispensable” for Jurkat cell apoptosis. However they did not explain how poly (I:C) triggered the activation of cell apoptosis, especially, whether TLR3 or related molecules was associated with this process. In our case, we first demonstrate the contribution of poly (I:C) to chicken T-cell lymphoma apoptosis rather than necrotic, which is different from Jurkat cells. And we explored the death signaling pathways involved in poly (I:C)-induced apoptosis of chicken lymphoma cells.
According to previous research, the mechanisms by which the activation of TLR3 triggers apoptosis are diverse in different cells. A type I IFN response induced by TLR3 pathway can be involved in tumor cells death directly or indirectly. IRF3 is thought to play an essential role in the TLR3-mediated apoptosis of prostate cancer cells and ovarian cancer cells by activating intrinsic and extrinsic apoptotic pathways3, 23, 25. However, poly (I:C)-induced MDCC-MSB1 cell apoptosis occurs independently of above pathway. Although the transcription of IFN-β mRNA was dramatically increased, the signs of apoptosis were still observed after cells were treated with specific inhibitor to block IRF3 activation and IFN-β production. Furthermore, there are several MDV-encoded miRNAs and proteins expressed in MDCC-MSB1 cells, which behave quite differently with other tumors26, 27. Many types of viral proteins have been identified as inhibitors of STAT1, an indispensable nucleus transcription factor that promotes transcription of interferon-stimulated genes (ISGs)28,29,30,31 and also plays an important role in type I IFN-induced apoptosis32,33,34. It is unclear whether MDV-encoded proteins have a similar capacity to interfere with the type I IFN pathway participating in apoptosis. In short, the production of IFN-β induced by TLR3 activation did not contribute to poly (I:C)-triggered apoptosis of MDCC-MSB1 cells.
Instead, poly (I:C)-induced MDCC-MSB1 cell apoptosis required the activation of NF-κB. In the presence of specific inhibitors to block activation of NF-κB, the percentage of apoptotic cells was significantly decreased, and caspase activity was also obviously down-regulated. NF-κB function in the regulation of cell death is quite complex35. In most cases, a role for NF-κB in resistance to cell death is initially apparent in several cell types6, 36,37,38,39,40,41. Downstream cytokines of NF-κB, such as IL-1β and IL-6 can protect cells to apoptosis42, 43. In this case, NF-κB plays a pro-apoptotic role in poly (I:C)-triggered apoptosis of MDCC-MSB1 cell. For example, an autocrine effect of TNF-α induced by NF-κB activation has previously been found during the apoptotic activation of human alveolar macrophages44. p53 directly interacts with Bak, liberating Bak from inhibitory complexes45. The crucial event for initiating the intrinsic mitochondria-mediated pathway of apoptosis is mitochondrial outer membrane permeabilization (MOMP) that requires the activation of Bak46. p53 can mediate apoptosis through inducing mitochondrial release of pro-apoptotic factors, and NF-κB is necessary for this event47. Other data have also shown that NF-κB activation render cells more sensitive to certain pro-apoptotic stimuli48,49,50,51,52. Furthermore, activation of NF-κB crucially contributes to apoptosis of T-cell lymphoma via Fas-dependent pathway, suggesting the pro-apoptotic of NF-κB in T-cell lymphoma apoptosis53, 54. Fas is a member of the death receptor family, recruiting FADD and caspase 8 to the death-inducing signaling complex to extrinsic apoptosis pathway55, 56. We detected high expression of the Fas and pro-apoptotic factors regulated by p53 during MDCC-MSB1 cell apoptosis. Moreover, the suppression of NF-κB activation significantly decreased the transcription of Fas and Bak. All the results were consistent with conclusions above mentioned showing that NF-κB plays a pro-apoptotic role in poly (I:C)-triggered apoptosis of MDCC-MSB1 cells.
During the process of apoptosis, caspase 3, caspase 8 and caspase 9 were activated and general caspase inhibitor completely abolished the activity of caspase to trigger MDCC-MSB1 cell apoptosis. This suggests that the caspase apoptotic pathway acts as an effector to perform apoptosis after poly(I:C) stimulation. In fact, a number of mechanisms to bridge TLR3 pathway and caspase cascade have been described to date. For example, TLR3 activation induces TAp63α, a p53-related protein, which contributes to the activation of caspase 8 and caspase 9 via death receptors and mitochondria in human umbilical vein endothelial cells57. Activation of TLR3 by dsRNA recruits caspase 8 to form a death-signalling complex in the presence of RIP1, which appears not to be stringently dependent on Fas-associated with death domain (FADD) and results in initiation of the extrinsic apoptosis pathway in lung cancer cells58. RIP1 is necessary for the recruitment of caspase 8 to TLR3. cIAPs-mediated ubiquitination of RIP can negatively regulate TLR3 to caspase 8 death complex formation and apoptosis. This report not only showed the direct activation of caspase-8 by TLR3 without FADD but also reflected the important role of RIP1 in TLR3-mediated apoptosis. Considering the inhibition of type I IFN and cytokines induced by TLR3, perhaps the adaptors involved in the TLR3 pathway are vital for activating the caspase cascade to induce apoptosis in our case.
Adaptors involved in the TLR3 pathway also exhibit the capacity to regulate proliferation and apoptosis. RIP1 is one of the core adaptors in the apoptotic pathway that induces NF-κB activation to control the expression of proteins associated with cell death and survival59. We detected significantly high expression of the RIP1 transcript during MDCC-MSB1 cell apoptosis, strongly suggesting that RIP1 contributes to apoptosis. In addition to RIP1, as mentioned above, TRAF6 directly interacts with the death effect domain of pro-caspase 8 through the C-terminal TRAF domain and activates caspase 8 through the N-terminal RING domain in humans60. TRIF has been proven to be a key molecule for apoptosis regulation. Apoptosis triggered by TRIF is depend on its receptor-interacting protein homotypic interaction motif61. And TRIF is critical for TLR3-induced activation of NF-κB11. In our case, TRIF inhibitor could significantly suppress MDCC-MSB1 cell apoptosis induced by poly(I:C). TRIF may directly trigger cell apoptosis. On the other hand, TRIF acting NF-κB was critical for MDCC-MSB1 cell apoptosis induced by ply(I:C). Although TRIF is a core adaptor in TLR3 pathway, it is also regarded as a critical component of other RNA sensors pathway. Zhang, Z. et al. reported that DDX1, DDX21 and DHX36 helicases formed a complex with the adaptor molecule TRIF to sense dsRNA in dendritic cells62. It should be investigated whether other RNA helicases can trigger or regulate cell apoptosis in chicken T cells in future.
Although the original goal was to trigger an innate immune response against chicken T-cell lymphoma, the above data suggest that TLR3 agonists might have a direct pro-apoptotic effect on tumour cells. However, not every lymphoma cell line we tested showed apoptotic induction after poly (I:C) treatment. For example, the avian leukosis virus (ALV) lymphoma-derived chicken cell line DT40 was tested, and no simple correlation was apparent between TLR3 expression in the resting state and poly (I:C)-induced apoptosis. Moreover, TLR3 activation is also unable to cause normal CD4+ T cell death. Why does TLR3 activation lead to such different outcome? Ripoptosome is a large cell death-inducing platform, which consists of core components RIP1, FADD and caspase 8 independently of TNF, CD95L/FasL, TRAIL, death-receptors, and mitochondrial pathways63. Ripoptosome formation was found with a capacity of converting pro-inflammatory cytokines into prodeath signals. cFLIP isoforms differentially regulate TLR3-mediated cell death by regulation of the ripoptosome64. In other words, ripoptosome maybe a switch controlled the convert of TLR3 function between induction of pro-inflammatory and pro-apoptosis. Whether there is the formation of ripoptosome during poly (I:C)-induced MDCC-MSB1 cell apoptosis, it might be an important unanswered question that should be focused on in subsequent work. To conclude, these data inspire the application of poly (I:C) as antiviral or anti-tumour agents against certain types of lymphoma or oncoviral infections because they can directly kill the tumour and enhance the host’s immune response against it.
Methods
Cells and reagents
The MDCC-MSB1 cell line, a Marek’s disease lymphoma-derived chicken cell line, was cultured at 38.5 °C in 5% CO2 in RPMI 1640 medium (Gibco, USA) containing 10% fetal calf serum (Gibco, Australia) and 10% tryptose phosphate broth (Sigma-Aldrich, USA). Avian leukosis virus (ALV) lymphoma-derived chicken cell line DT40 was cultured at 38.5 °C in 5% CO2 in RPMI 1640 medium (Gibco, USA) containing 10% fetal calf serum (Gibco, Australia), 5% chicken serum (Gibco, USA) and 5% tryptose phosphate broth (Sigma-Aldrich, USA). Poly (I:C) was obtained from Sigma-Aldrich (USA). The pan-caspase inhibitor Z-VAD-FMK was purchase from Beyotime Biotechnology (Nantong, China). The inhibitors Pepinh-TRIF, resveratrol, BX795, and 2-aminopurine were purchase from InvivoGen (USA). Necrostatin-1 and BAY11-7082 was purchased from Abcam (USA).
Cell viability analysis
CCK-8 cell survival assays were performed according to the manufacturer’s instructions (Beyotime Biotechnology, Nantong, China). Briefly, cells were seeded at 5 × 104 cells/well in 96-well plates, and after 8, 16, or 24 h culture with or without poly (I:C), CCK-8 reagent was added to culture medium. After incubate at 37 °C for 4 h, the absorbance of each well was read at 450 nm. The results were calculated as the absorbance ratio of poly (I:C)-treated to untreated cells.
Detection of apoptotic cells
For apoptosis measurements, harvested cells were stained with FITC Annexin V Apoptosis Detection Kit I (BD Pharmingen, USA) according to the manufacturer’s instructions. Harvested cells were washed with cold PBS twice and resuspended in binding buffer containing annexin V-FITC and PI. Cell populations labeled with FITC and PI were analyzed by flow cytometry (CyAn ADP7, Beckman Coulter) with Summit 4.3 software (Beckman Coulter), and showed as a percentage.
Determination of caspase activity
The activity of caspases 3/7, 8, and 9 was detected using the Caspase Glo assay kit (Promega, USA) according to the manufacturer’s instructions. Briefly, cells were seeded at a density of 5 × 104 cells/wells in 96-well plates, and after 8, 16, or 24 h culture with or without poly (I:C), 100 μL Caspase Glo reagent was added to the culture medium. After mixing, the cells were transferred to a 96-well white-wall plate for incubation at room temperature in the dark for 30 min. The luminescence of the samples was measured with a luminometer (Glomax multi+, Promega). Luciferase activity was normalized against the amount of total protein. The fold change in protease activity was calculated by comparing the luciferase activity of the treated cells with that of the untreated cells.
Determination of the mitochondrial membrane potential (MMP)
Cells treated with poly (I:C) was collected and washed twice with cold PBS. The pipetted cell was re-suspended with PBS supplemented with 5 μM JC-1 dye (Sigma-Aldrich, USA). After incubation at 37 °C for 15 min, the cells were observed with a fluorescence microscope.
Real-time PCR
Total RNA was extracted from cells with Trizol (Invitrogen), and cDNA was synthesized using PrimeScript™ RT reagent Kit (Takara, Dalian, China). Real-time PCR was performed using SYBR Premix ExTaq II (Takara Dalian, China) in an ABI 7500 real-time PCR system (Applied Biosystems, CA, USA). The specific primers used for real-time PCR were designed according to previously published sequences and shown in Table 1. The mRNA expression level was normalized against the level of chicken GAPDH mRNA. The fold change of all genes expression was calculated by the 2−ΔΔCt method.
Western-blot
Cells were lysed with RIPA buffer with protease inhibitors. The samples were loaded with 5 × denaturing sample buffer and separated by 12% SDS-PAGE. The proteins were transferred to 0.2 μm nitrocellulose (NC) membrane and were subsequently analysed by immunoblot with the relevant antibodies. The blots were developed by using chemiluminescence (Protein Simple, Fluorchem E FE0605). The monoclonal antibody used to detect GAPDH was from Abcam (Cat. No. ab9484) and the polyclonal antibody to TLR3 was from Novus Biologicals (NBP2-24565). Polyclonal antibodies to NF-κB p65 and PKR were obtained from rabbit immunized with peptides, which are prepared by Genscript (Nanjing, China).
Statistical analysis
The statistical analysis was performed with Student’s t test using GraphPad PRISM 6 software. P values less than 0.05 were considered statistically significant.
References
Takeuchi, O. & Akira, S. Innate immunity to virus infection. Immunol Rev 227, 75–86, doi:10.1111/j.1600-065X.2008.00737.x (2009).
Dogusan, Z. et al. Double-stranded RNA induces pancreatic beta-cell apoptosis by activation of the toll-like receptor 3 and interferon regulatory factor 3 pathways. Diabetes 57, 1236–1245, doi:10.2337/db07-0844 (2008).
Van, D. N. et al. Innate immune agonist, dsRNA, induces apoptosis in ovarian cancer cells and enhances the potency of cytotoxic chemotherapeutics. FASEB J 26, 3188–3198, doi:10.1096/fj.11-202333 (2012).
McAllister, C. S. & Samuel, C. E. The RNA-activated protein kinase enhances the induction of interferon-beta and apoptosis mediated by cytoplasmic RNA sensors. J Biol Chem 284, 1644–1651, doi:10.1074/jbc.M807888200 (2009).
McAllister, C. S. et al. TLR3, TRIF, and caspase 8 determine double-stranded RNA-induced epithelial cell death and survival in vivo. J Immunol 190, 418–427, doi:10.4049/jimmunol.1202756 (2013).
Umemura, N. et al. Defective NF-kappaB signaling in metastatic head and neck cancer cells leads to enhanced apoptosis by double-stranded RNA. Cancer Res 72, 45–55, doi:10.1158/0008-5472.CAN-11-1484 (2012).
Taura, M. et al. TLR3 induction by anticancer drugs potentiates poly I:C-induced tumor cell apoptosis. Cancer Sci 101, 1610–1617, doi:10.1111/j.1349-7006.2010.01567.x (2010).
Paone, A. et al. Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-alpha-dependent mechanism. Carcinogenesis 29, 1334–1342, doi:10.1093/carcin/bgn149 (2008).
Salaun, B., Coste, I., Rissoan, M. C., Lebecque, S. J. & Renno, T. TLR3 can directly trigger apoptosis in human cancer cells. J Immunol 176, 4894–4901 (2006).
Paone, A. et al. Toll-like receptor 3 regulates angiogenesis and apoptosis in prostate cancer cell lines through hypoxia-inducible factor 1 alpha. Neoplasia 12, 539–549 (2010).
Kawai, T. & Akira, S. SnapShot: Pattern-recognition receptors. Cell 129, 1024, doi:10.1016/j.cell.2007.05.017 (2007).
Chattopadhyay, S. et al. Viral apoptosis is induced by IRF-3-mediated activation of Bax. EMBO J 29, 1762–1773, doi:10.1038/emboj.2010.50 (2010).
Christofferson, D. E., Li, Y. & Yuan, J. Control of life-or-death decisions by RIP1 kinase. Annual review of physiology 76, 129–150, doi:10.1146/annurev-physiol-021113-170259 (2014).
Yu, M., Lam, J., Rada, B., Leto, T. L. & Levine, S. J. Double-stranded RNA induces shedding of the 34-kDa soluble TNFR1 from human airway epithelial cells via TLR3-TRIF-RIP1-dependent signaling: roles for dual oxidase 2- and caspase-dependent pathways. J Immunol 186, 1180–1188, doi:10.4049/jimmunol.1001499 (2011).
Park, H., Huang, X., Lu, C., Cairo, M. S. & Zhou, X. MicroRNA-146a and microRNA-146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteins. J Biol Chem 290, 2831–2841, doi:10.1074/jbc.M114.591420 (2015).
Weber, A. et al. Proapoptotic signalling through Toll-like receptor-3 involves TRIF-dependent activation of caspase-8 and is under the control of inhibitor of apoptosis proteins in melanoma cells. Cell Death Differ 17, 942–951, doi:10.1038/cdd.2009.190 (2010).
Osterrieder, N., Kamil, J. P., Schumacher, D., Tischer, B. K. & Trapp, S. Marek’s disease virus: from miasma to model. Nature reviews. Microbiology 4, 283–294, doi:10.1038/nrmicro1382 (2006).
Burgess, S. C. et al. Marek’s disease is a natural model for lymphomas overexpressing Hodgkin’s disease antigen (CD30). Proc Natl Acad Sci USA 101, 13879–13884, doi:10.1073/pnas.0305789101 (2004).
Hu, X. et al. Marek’s disease virus may interfere with T cell immunity by TLR3 signals. Veterinary research communications. doi:10.1007/s11259-014-9598-x (2014).
Jie, H. et al. Differential expression of Toll-like receptor genes in lymphoid tissues between Marek’s disease virus-infected and noninfected chickens. Poultry science 92, 645–654, doi:10.3382/ps.2012-02747 (2013).
Parvizi, P. et al. A toll-like receptor 3 ligand enhances protective effects of vaccination against Marek’s disease virus and hinders tumor development in chickens. Viral immunology 25, 394–401, doi:10.1089/vim.2012.0033 (2012).
Weiss, R. et al. IL-24 sensitizes tumor cells to TLR3-mediated apoptosis. Cell Death Differ 20, 823–833, doi:10.1038/cdd.2013.15 (2013).
Gambara, G. et al. TLR3 engagement induces IRF-3-dependent apoptosis in androgen-sensitive prostate cancer cells and inhibits tumour growth in vivo. J Cell Mol Med 19, 327–339, doi:10.1111/jcmm.12379 (2015).
Kalai, M. et al. Tipping the balance between necrosis and apoptosis in human and murine cells treated with interferon and dsRNA. Cell Death Differ 9, 981–994, doi:10.1038/sj.cdd.4401051 (2002).
Bernardo, A. R., Cosgaya, J. M., Aranda, A. & Jimenez-Lara, A. M. Synergy between RA and TLR3 promotes type I IFN-dependent apoptosis through upregulation of TRAIL pathway in breast cancer cells. Cell Death Dis 4, e479, doi:10.1038/cddis.2013.5 (2013).
Xie, Q., Anderson, A. S. & Morgan, R. W. Marek’s disease virus (MDV) ICP4, pp38, and meq genes are involved in the maintenance of transformation of MDCC-MSB1 MDV-transformed lymphoblastoid cells. J Virol 70, 1125–1131 (1996).
Yao, Y. et al. MicroRNA profile of Marek’s disease virus-transformed T-cell line MSB-1: predominance of virus-encoded microRNAs. J Virol 82, 4007–4015, doi:10.1128/JVI.02659-07 (2008).
Kumthip, K. et al. Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling. J Virol 86, 8581–8591, doi:10.1128/JVI.00533-12 (2012).
Nagel, M. A. et al. Inhibition of phosphorylated-STAT1 nuclear translocation and antiviral protein expression in human brain vascular adventitial fibroblasts infected with varicella-zoster virus. J Virol 88, 11634–11637, doi:10.1128/JVI.01945-14 (2014).
Lin, W. et al. Hepatitis C virus expression suppresses interferon signaling by degrading STAT1. Gastroenterology 128, 1034–1041 (2005).
Lin, W. et al. Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain. J Virol 80, 9226–9235, doi:10.1128/JVI.00459-06 (2006).
Rasschaert, J. et al. Toll-like receptor 3 and STAT-1 contribute to double-stranded RNA+ interferon-gamma-induced apoptosis in primary pancreatic beta-cells. J Biol Chem 280, 33984–33991, doi:10.1074/jbc.M502213200 (2005).
Takaoka, A. et al. Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature 424, 516–523, doi:10.1038/nature01850 (2003).
Chin, Y. E., Kitagawa, M., Kuida, K., Flavell, R. A. & Fu, X. Y. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol 17, 5328–5337 (1997).
Burstein, E. & Duckett, C. S. Dying for NF-κB? Control of cell death by transcriptional regulation of the apoptotic machinery. Current Opinion in Cell Biology 15, 732–737, doi:10.1016/j.ceb.2003.10.005 (2003).
Liu, R. et al. FOXP3 Controls an miR-146/NF-kappaB Negative Feedback Loop That Inhibits Apoptosis in Breast Cancer Cells. Cancer Res 75, 1703–1713, doi:10.1158/0008-5472.CAN-14-2108 (2015).
Wang, C. Y., Mayo, M. W. & Baldwin, A. S. Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274, 784–787 (1996).
Dong, Q. G. et al. The function of multiple IkappaB: NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis. Oncogene 21, 6510–6519, doi:10.1038/sj.onc.1205848 (2002).
Zhang, S. et al. Suppressed NF-kappaB and sustained JNK activation contribute to the sensitization effect of parthenolide to TNF-alpha-induced apoptosis in human cancer cells. Carcinogenesis 25, 2191–2199, doi:10.1093/carcin/bgh234 (2004).
Fulda, S. & Debatin, K. M. Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer Res 64, 337–346 (2004).
Lu, B. et al. Regulation of Fas (CD95)-induced apoptosis by nuclear factor-kappaB and tumor necrosis factor-alpha in macrophages. Am J Physiol Cell Physiol 283, C831–838, doi:10.1152/ajpcell.00045.2002 (2002).
Kuhn, K., Hashimoto, S. & Lotz, M. IL-1 beta protects human chondrocytes from CD95-induced apoptosis. J Immunol 164, 2233–2239 (2000).
Lin, M. T., Juan, C. Y., Chang, K. J., Chen, W. J. & Kuo, M. L. IL-6 inhibits apoptosis and retains oxidative DNA lesions in human gastric cancer AGS cells through up-regulation of anti-apoptotic gene mcl-1. Carcinogenesis 22, 1947–1953 (2001).
Means, T. K. et al. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses. J Immunol 166, 4074–4082 (2001).
Vaseva, A. V. & Moll, U. M. The mitochondrial p53 pathway. Biochim Biophys Acta 1787, 414–420, doi:10.1016/j.bbabio.2008.10.005 (2009).
Youle, R. J. & Strasser, A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9, 47–59, doi:10.1038/nrm2308 (2008).
Ryan, K. M., Ernst, M. K., Rice, N. R. & Vousden, K. H. Role of NF-kappaB in p53-mediated programmed cell death. Nature 404, 892–897, doi:10.1038/35009130 (2000).
Kimura, M. et al. TNF combined with IFN-alpha accelerates NF-kappaB-mediated apoptosis through enhancement of Fas expression in colon cancer cells. Cell Death Differ 10, 718–728, doi:10.1038/sj.cdd.4401219 (2003).
Stark, L. A. et al. Aspirin activates the NF-kappaB signalling pathway and induces apoptosis in intestinal neoplasia in two in vivo models of human colorectal cancer. Carcinogenesis 28, 968–976, doi:10.1093/carcin/bgl220 (2007).
Brady, R. R., Loveridge, C. J., Dunlop, M. G. & Stark, L. A. c-Src dependency of NSAID-induced effects on NF-kappaB-mediated apoptosis in colorectal cancer cells. Carcinogenesis 32, 1069–1077, doi:10.1093/carcin/bgr077 (2011).
Chan, H., Bartos, D. P. & Owen-Schaub, L. B. Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment. Mol Cell Biol 19, 2098–2108 (1999).
Harwood, F. G. et al. Regulation of FasL by NF-kappaB and AP-1 in Fas-dependent thymineless death of human colon carcinoma cells. J Biol Chem 275, 10023–10029 (2000).
Kasibhatla, S. et al. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. Molecular cell 1, 543–551 (1998).
Kasibhatla, S., Genestier, L. & Green, D. R. Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB. J Biol Chem 274, 987–992 (1999).
Kaufmann, T., Strasser, A. & Jost, P. J. Fas death receptor signalling: roles of Bid and XIAP. Cell Death Differ 19, 42–50, doi:10.1038/cdd.2011.121 (2012).
Lavrik, I. N. & Krammer, P. H. Regulation of CD95/Fas signaling at the DISC. Cell Death Differ 19, 36–41, doi:10.1038/cdd.2011.155 (2012).
Sun, R. et al. Toll-like receptor 3 (TLR3) induces apoptosis via death receptors and mitochondria by up-regulating the transactivating p63 isoform alpha (TAP63alpha). J Biol Chem 286, 15918–15928, doi:10.1074/jbc.M110.178798 (2011).
Estornes, Y. et al. dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8. Cell Death Differ 19, 1482–1494, doi:10.1038/cdd.2012.22 (2012).
Weinlich, R. & Green, D. R. The two faces of receptor interacting protein kinase-1. Molecular cell 56, 469–480, doi:10.1016/j.molcel.2014.11.001 (2014).
He, L., Wu, X., Siegel, R. & Lipsky, P. E. TRAF6 regulates cell fate decisions by inducing caspase 8-dependent apoptosis and the activation of NF-kappaB. J Biol Chem 281, 11235–11249, doi:10.1074/jbc.M508779200 (2006).
Kaiser, W. J. & Offermann, M. K. Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif. Journal of Immunology 174, 4942–4952 (2005).
Zhang, Z. et al. DDX1, DDX21, and DHX36 helicases form a complex with the adaptor molecule TRIF to sense dsRNA in dendritic cells. Immunity 34, 866–878, doi:10.1016/j.immuni.2011.03.027 (2011).
Tenev, T. et al. The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Molecular cell 43, 432–448, doi:10.1016/j.molcel.2011.06.006 (2011).
Feoktistova, M. et al. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Molecular cell 43, 449–463, doi:10.1016/j.molcel.2011.06.011 (2011).
Acknowledgements
This research was supported by the National Natural Science Foundation of China (31472192, U1604232, 31272560), The National Key Research and Development program of China (2016YFD0500803), Special Foundation for State Basic Research Program of China (2013FY113300-4) and the Priority Academic Program Development of Jiangsu Higher Education Institutions.
Author information
Authors and Affiliations
Contributions
H.T.Z. and A.J.Q. conceived and designed the experiments; H.T.Z. and R.X.S. performed the experiments; H.T.Z., A.J.Q., K.Q., H.X.S. and J.Q.Y. analyzed the data; H.T.Z., J.R., K.Q. and H.X.S. contributed reagents/materials/analysis tools; Y.X.Y. and V.N. discussed and analyzed in detail. H.T.Z. and A.J.Q. contributed to the writing of the manuscript. H.T.Z. prepared figures. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Competing Interests
The authors declare that they have no competing interests.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zou, H., Su, R., Ruan, J. et al. Double-stranded RNA induces chicken T-cell lymphoma apoptosis by TRIF and NF-κB. Sci Rep 7, 7547 (2017). https://doi.org/10.1038/s41598-017-07919-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-017-07919-w
- Springer Nature Limited